Volume 8, Issue 3, Page 15 (March 2010)
11 of 22
PREVIEW
FULL TEXT
FULL-TEXT PDF (114 KB)
CITATION ALERT
CITED BY
RELATED ARTICLES
EXPORT CITATION
EMAIL TO A COLLEAGUE
RIGHTS/PERMISSIONS
NEED REPRINTS?
BOOKMARK ARTICLE
GAITHERSBURG, MD. — Black box warnings added to the labels of all gadolinium-based MRI contrast agents have reduced the number of reported nephrogenic systemic fibrosis events to almost none in the last year, according to Dr. James Kaiser.
PII: S1544-8800(10)70092-0
doi:10.1016/S1544-8800(10)70092-0
© 2010 Elsevier Inc. All rights reserved.
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.